HOME >> MEDICINE >> NEWS
Treatment for behavioral disorders in children with autism

One of a newer class of anti-psychotic medications was successful and well tolerated for the treatment of serious behavioral disturbance associated with autistic disorder in children ages 5 to 17. The findings of the large, multi-site, eight-week, placebo-controlled clinical trial, which was funded by the National Institute of Mental Health (NIMH), are being published this week in the New England Journal of Medicine.

"Although this study did not attempt to treat the core symptoms of autism, our findings suggest that risperidone can be useful in treating moderate to severe behavior problems that are associated with autism in children," said Lawrence Scahill, Ph.D., principal investigator at the Yale Child Study Center site.

Autism is a chronic condition that appears in early childhood and is characterized by core symptoms of impaired social relatedness, delayed language, and restricted patterns of behavior. It affects as many as 20 children per 10,000. Although the causes of autism are unknown for most cases, available evidence implicates abnormalities in brain development. Twin and family studies indicate a strong genetic contribution.

In addition to core symptoms, children with autism frequently exhibit serious behavior disturbances, such as self-injury, aggression, hyperactivity, and tantrums in response to routine environmental demands. For these disturbances, behavior therapy and medications are the two main forms of treatment.

In this multi-site study, researchers randomly assigned 101 children and adolescents, 82 boys and 19 girls, age 5 to 17, to receive either placebo or risperidone, one of a new class of anti-psychotics called atypical.

The study found risperidone to be significantly more effective than placebo in improving behavior. Using a stringent definition of improvement, 69% of the children randomly assigned to risperidone were much or very much improved at the end of the study, as compared with
'"/>

Contact: Rayford Kytle
NIMHpress@nih.gov
301-443-4536
NIH/National Institute of Mental Health
31-Jul-2002


Page: 1 2

Related medicine news :

1. Treatment of cardiac lesions without anaesthesic
2. Treatment guidelines for kids with bipolar disorder published
3. University of Washington joins new Autism Treatment Network to provide better medical services
4. Treatment for brain tumor does not always follow recommendations
5. Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis: A scientific meeting
6. Treatment of ductal carcinoma in situ varies widely in United States
7. Treatment options expand for patients with neuropathic pain
8. Treatment interruption shows no benefit in drug-resistant HIV infection
9. Peanut Allergy: Major Advances in Treatment and Education
10. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
11. Treatment helped reduce dose of inhaled corticosteroids while maintaining asthma control

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2020)... ... , ... The value of healthy vision can’t be overstated, and the most ... care doctor, Brent Bellotte MD., champions such proactive care, advising that annual examinations are ... something that many take for granted until a problem occurs. Eye disease is very ...
(Date:1/8/2020)... ... January 08, 2020 , ... ... a workplace of the future powered by the Myant Platform at CES ... how an office environment connected to the Myant Platform will be aware of ...
(Date:1/7/2020)... Texas (PRWEB) , ... January 07, 2020 , ... ... today unveiled another facility expansion, adding to the company’s 200,000 sq. ft. manufacturing ... 25,000 sq. ft. of manufacturing space dedicated to POD architectural, mechanical, electrical and ...
(Date:1/7/2020)... NEW YORK (PRWEB) , ... January 07, 2020 , ... ... launched a year-long Facebook fundraiser to help others living with YOPD attend the 6th ... fundraiser for two weeks, running back to back to cover all 52 weeks in ...
(Date:1/7/2020)... ... January 07, 2020 , ... R3 ... which includes comprehensive presentations and procedures for hair restoration, facial rejuvenation and sexual ... available. , Regenerative aesthetics has become incredibly popular over the past few years ...
Breaking Medicine News(10 mins):
(Date:1/8/2020)... , ... January 08, 2020 ... ... that they are now able to accept Medicare for medication-assisted treatment services ... with methadone, buprenorphine and naltrexone, all FDA-approved medications, as well as counseling, ...
(Date:1/7/2020)... ... January 07, 2020 , ... Valencell ... system for integration in hearables and wearables. Valencell will provide the BP sensor ... inclusion in their products. Embedded in an earbud reference design, the technology has ...
(Date:1/7/2020)... (PRWEB) , ... January 06, 2020 , ... Myant Inc., ... enable continuous and ambient heart health management at CES 2020 (January 7-10, Las Vegas), ... a winner in the Health & Wellness category of the CES 2020 Innovation Awards. ...
Breaking Medicine Technology:
Cached News: